Bnp Paribas Asset Management Holding S.A. Bicycle Therapeutics PLC Transaction History
Bnp Paribas Asset Management Holding S.A.
- $40.4 Billion
- Q3 2024
A detailed history of Bnp Paribas Asset Management Holding S.A. transactions in Bicycle Therapeutics PLC stock. As of the latest transaction made, Bnp Paribas Asset Management Holding S.A. holds 759,887 shares of BCYC stock, worth $15.2 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
759,887
Previous 888,081
14.43%
Holding current value
$15.2 Million
Previous $18 Million
4.33%
% of portfolio
0.04%
Previous 0.05%
Shares
8 transactions
Others Institutions Holding BCYC
# of Institutions
112Shares Held
41.2MCall Options Held
39.6KPut Options Held
24.6K-
Baker Bros. Advisors LP New York, NY9.4MShares$188 Million2.28% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.55MShares$71 Million2.97% of portfolio
-
Fcpm Iii Services B.V. Naarden, P72.34MShares$46.8 Million9.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA2.25MShares$45.1 Million0.71% of portfolio
-
Armistice Capital, LLC New York, NY1.96MShares$39.1 Million0.74% of portfolio
About BICYCLE THERAPEUTICS plc
- Ticker BCYC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,676,100
- Market Cap $594M
- Description
- Bicycle Therapeutics plc, a clinical-stage biopharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics. Its lead product candidate is BT1718, a bicycle toxin conjugate (BTC), which is in Phase I/IIa clinical trials targeting tumors that express Membrane Type 1 matrix metalloprotease. The co...